Tamgiblimab (IBI939) 是一种全人源单克隆抗体，靶向具有免疫球蛋白和 ITIM 结构域的 T 细胞免疫受体 (TIGIT)。Tamgiblimab 具有抗癌作用。
| 生物活性 | Tamgiblimab (IBI939) is a fully human monoclonal antibody targetingT-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT). Tamgiblimab has anticancer effects[1]. |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
